| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $0.00 | $18.94M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $241.65M | $196.92M | $190.65M | $132.14M | $86.90M |
| R&D | $187.40M | $142.90M | $148.16M | $91.95M | $57.75M |
| SG&A | $54.25M | $54.02M | $42.49M | $40.19M | $29.15M |
| Operating Income | -$241.65M | -$196.92M | -$191.09M | $144.65M | -$67.95M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $117.00K | -$14.12M | $42.12M | $0.00 |
| Net Income | -$219.88M | -$167.38M | -$153.16M | $111.21M | -$65.57M |
| EPS (basic) | – | – | -3.6900 | 2.4600 | -1.5200 |
| EPS (diluted) | – | – | -3.6900 | 2.3800 | -1.5200 |
| Shares (diluted) | – | – | $41.55M | $46.64M | $43.08M |